PRAMIPEXOLE GxP pramipexole dihydrochloride 0.25 mg tablets blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

pramipexole dihydrochloride monohydrate

Zāļu forma:

Tablet, uncoated

Kompozīcija:

Excipient Ingredients: mannitol; pregelatinised maize starch; magnesium stearate; povidone; silicon dioxide

Ievadīšanas:

Oral

Vienības iepakojumā:

10, 30, 100

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Produktu pārskats:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizācija statuss:

Licence status A

Autorizācija datums:

2014-09-23